 |
|
|
| |
Treatment of Hepatitis C Genotype 4 with Ledipasvir and Sofosbuvir for 12 weeks: Results of the SYNERGY Trial
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Rama Kapoor1, Anita Kohli1, Sreetha Sidharthan2, Zayani Sims2, Tess Petersen2, Anu Osinusi3, Amy K. Nelson3, Rachel Silk1, Colleen Kotb1, Kate Sugarman4, Brian P. Lam5,Phillip S. Pang6, Mani Subramanian6, John G. McHutchison6, Henry Masur2, Shyam Kottilil3, Vinod K. Rustgi7
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Department of Health and Human Services
Bethesda, MD
|
| |
|
|
|
|
|
